Dr. Shaw is an emergency medicine physician, clinical epidemiologist, and national leader in the fields of pediatric emergency medicine and quality and patient safety. She is most noted for her research in the diagnosis and management of acute pediatric illness and injuries, most notably UTI,
dehydration, and bronchiolitis.
Dr. Mollen's research career has been focusing on using non traditional setting as sites for interventions to improve adolescent reproductive health. She founded and oversees a research program in Children's Hospital of Philadelphia's Emergency Department that provides sexual health education and HIV testing services, and explores intervention opportunities for increasing access to reproductive health services in the ED.
Dr. Corwin’s research focuses on pediatric concussion. He has a particular interest in improving the diagnosis and initial management of pediatric concussion, specifically using specialized examination techniques to identify shortly following the injury those children at highest risk for a prolonged recovery, as well as ways to maximize the diagnostic accuracy from the Emergency Department.
Dr. Zorc's work focuses on the intersection of interventional clinical research, quality improvement (QI), and clinical informatics. He has formal certification in epidemiology, QI methodology, and clinical informatics, and has participated in multi-center research networks, guideline and improvement collaboratives, and electronic health record development locally and nationally.
Dr. Johnson's research portfolio reflects her commitment to improving the quality of care for underserved children and reducing racial/ethnic inequities. Her current interdisciplinary research program is focused on inequities in the care and outcomes of children in the emergency department.
Dr. Scribano's areas of interest and research involve the epidemiology and prevention of child maltreatment and intimate partner violence, technology use in healthcare, and health services to children in foster care.
Dr. Snyder is a pediatric hematologist oncologist focused on improving the lives of people living with vascular anomalies. She is involved with national and international endeavors to create educational programs and investigational registries, investigate treatments, and author publications in this discipline.
Dr. Ackermann studies diabetes (types 1 and 2) and congenital hyperinsulinism using mouse models, cell lines, and primary human tissue. She aims to identify novel pathways regulating beta cell insulin secretion, leading to innovative therapeutic strategies for these disorders. Current studies include in vivo mouse physiology, ex vivo human islet physiology, CRISPR-Cas9 gene editing, epigenetic modification, and single-cell functional genomics.